APO Research
Talk to an analyst

APO RESEARCH · REPORT

Filgotinib Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Filgotinib Tablets Market Outlook and Growth Opportunities 2026

29 December 2025198 pages

Choose your research edition.

Industry ResearchFilgotinib Tablets Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Filgotinib Tablets Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Filgotinib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Filgotinib Tablets Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Filgotinib Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Filgotinib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Filgotinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Filgotinib Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Filgotinib Tablets market include Alfasigma, Gilead Sciences and Eisai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Filgotinib Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Filgotinib Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Filgotinib Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Filgotinib Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Filgotinib Tablets Segment by Company

Alfasigma

Gilead Sciences

Eisai

Filgotinib Tablets Segment by Type

100mg per Tablet

200mg per Tablet

Filgotinib Tablets Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Filgotinib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Filgotinib Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Filgotinib Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Filgotinib Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Filgotinib Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgotinib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Filgotinib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgotinib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Filgotinib Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Filgotinib Tablets industry.

Chapter 3: Detailed analysis of Filgotinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Filgotinib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Filgotinib Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Filgotinib Tablets Industry Trends Table 2. Filgotinib Tablets Industry Drivers Table 3. Filgotinib Tablets Industry Opportunities and Challenges Table 4. Filgotinib Tablets Industry Restraints Table 5. Global Filgotinib Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Filgotinib Tablets Revenue Share by Company (2021-2026) Table 7. Global Filgotinib Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Filgotinib Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Filgotinib Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Filgotinib Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Filgotinib Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Filgotinib Tablets Company, Product Type & Application Table 13. Global Filgotinib Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Filgotinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg per Tablet Table 18. Significant Companies of 200mg per Tablet Table 19. Global Filgotinib Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Filgotinib Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Filgotinib Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Filgotinib Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Filgotinib Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Filgotinib Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Filgotinib Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Filgotinib Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Filgotinib Tablets Sales Value Share by Type (2021-2026) Table 28. Global Filgotinib Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacy Table 30. Significant Companies of Online Pharmacy Table 31. Significant Companies of Retail Pharmacy Table 32. Global Filgotinib Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Filgotinib Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Filgotinib Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Filgotinib Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Filgotinib Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Filgotinib Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Filgotinib Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Filgotinib Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Filgotinib Tablets Sales Value Share by Application (2021-2026) Table 41. Global Filgotinib Tablets Sales Value Share by Application (2027-2032) Table 42. Global Filgotinib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Filgotinib Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Filgotinib Tablets Sales Market Share by Region (2021-2026) Table 45. Global Filgotinib Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Filgotinib Tablets Sales Market Share by Region (2027-2032) Table 47. Global Filgotinib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Filgotinib Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Filgotinib Tablets Sales Value Share by Region (2021-2026) Table 50. Global Filgotinib Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Filgotinib Tablets Sales Value Share by Region (2027-2032) Table 52. Global Filgotinib Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Filgotinib Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Filgotinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Filgotinib Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Filgotinib Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Filgotinib Tablets Sales Market Share by Country (2021-2026) Table 58. Global Filgotinib Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Filgotinib Tablets Sales Market Share by Country (2027-2032) Table 60. Global Filgotinib Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Filgotinib Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Filgotinib Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Filgotinib Tablets Sales Value Market Share by Country (2027-2032) Table 64. Alfasigma Company Information Table 65. Alfasigma Business Overview Table 66. Alfasigma Filgotinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Alfasigma Filgotinib Tablets Product Portfolio Table 68. Alfasigma Recent Development Table 69. Gilead Sciences Company Information Table 70. Gilead Sciences Business Overview Table 71. Gilead Sciences Filgotinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Gilead Sciences Filgotinib Tablets Product Portfolio Table 73. Gilead Sciences Recent Development Table 74. Eisai Company Information Table 75. Eisai Business Overview Table 76. Eisai Filgotinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Eisai Filgotinib Tablets Product Portfolio Table 78. Eisai Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Filgotinib Tablets Distributors List Table 82. Filgotinib Tablets Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Filgotinib Tablets Product Image Figure 2. Global Filgotinib Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Filgotinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Filgotinib Tablets Sales (2021-2032) & (K Units) Figure 5. Global Filgotinib Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Filgotinib Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg per Tablet Image Figure 10. 200mg per Tablet Image Figure 11. Global Filgotinib Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Filgotinib Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Filgotinib Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Filgotinib Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Filgotinib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Filgotinib Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Retail Pharmacy Image Figure 20. Global Filgotinib Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Filgotinib Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Filgotinib Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Filgotinib Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Filgotinib Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Filgotinib Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Filgotinib Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Filgotinib Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Filgotinib Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Filgotinib Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Filgotinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Filgotinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Filgotinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Filgotinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Filgotinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Filgotinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Filgotinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Filgotinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Filgotinib Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Filgotinib Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Filgotinib Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Filgotinib Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Filgotinib Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg per Tablet
  • 200mg per Tablet
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Alfasigma
  • Gilead Sciences
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Filgotinib Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Filgotinib Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Filgotinib Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Filgotinib Tablets Market Dynamics
  1. 2.1 Filgotinib Tablets Industry Trends
  2. 2.2 Filgotinib Tablets Industry Drivers
  3. 2.3 Filgotinib Tablets Industry Opportunities and Challenges
  4. 2.4 Filgotinib Tablets Industry Restraints
3 Filgotinib Tablets Market by Company
  1. 3.1 Global Filgotinib Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Filgotinib Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Filgotinib Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Filgotinib Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Filgotinib Tablets Company Ranking (2024-2026)
  6. 3.6 Global Filgotinib Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Filgotinib Tablets Company Product Type and Application
  8. 3.8 Global Filgotinib Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Filgotinib Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Filgotinib Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Filgotinib Tablets Market by Type
  1. 4.1 Filgotinib Tablets Type Introduction
  2. 4.1.1 100mg per Tablet
  3. 4.1.2 200mg per Tablet
  4. 4.2 Global Filgotinib Tablets Sales Volume by Type
  5. 4.2.1 Global Filgotinib Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Filgotinib Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Filgotinib Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Filgotinib Tablets Sales Value by Type
  9. 4.3.1 Global Filgotinib Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Filgotinib Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Filgotinib Tablets Sales Value Share by Type (2021-2032)
5 Filgotinib Tablets Market by Application
  1. 5.1 Filgotinib Tablets Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Filgotinib Tablets Sales Volume by Application
  6. 5.2.1 Global Filgotinib Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Filgotinib Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Filgotinib Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Filgotinib Tablets Sales Value by Application
  10. 5.3.1 Global Filgotinib Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Filgotinib Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Filgotinib Tablets Sales Value Share by Application (2021-2032)
6 Filgotinib Tablets Regional Sales and Value Analysis
  1. 6.1 Global Filgotinib Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Filgotinib Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Filgotinib Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Filgotinib Tablets Sales by Region (2027-2032)
  5. 6.3 Global Filgotinib Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Filgotinib Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Filgotinib Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Filgotinib Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Filgotinib Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Filgotinib Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Filgotinib Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Filgotinib Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Filgotinib Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Filgotinib Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Filgotinib Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Filgotinib Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Filgotinib Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Filgotinib Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Filgotinib Tablets Sales Value Share by Country, 2025 VS 2032
7 Filgotinib Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Filgotinib Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Filgotinib Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Filgotinib Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Filgotinib Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Filgotinib Tablets Sales by Country (2027-2032)
  6. 7.4 Global Filgotinib Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Filgotinib Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Filgotinib Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Filgotinib Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Filgotinib Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Filgotinib Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alfasigma
  2. 8.1.1 Alfasigma Company Information
  3. 8.1.2 Alfasigma Business Overview
  4. 8.1.3 Alfasigma Filgotinib Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alfasigma Filgotinib Tablets Product Portfolio
  6. 8.1.5 Alfasigma Recent Developments
  7. 8.2 Gilead Sciences
  8. 8.2.1 Gilead Sciences Company Information
  9. 8.2.2 Gilead Sciences Business Overview
  10. 8.2.3 Gilead Sciences Filgotinib Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Gilead Sciences Filgotinib Tablets Product Portfolio
  12. 8.2.5 Gilead Sciences Recent Developments
  13. 8.3 Eisai
  14. 8.3.1 Eisai Company Information
  15. 8.3.2 Eisai Business Overview
  16. 8.3.3 Eisai Filgotinib Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eisai Filgotinib Tablets Product Portfolio
  18. 8.3.5 Eisai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Filgotinib Tablets Value Chain Analysis
  2. 9.1.1 Filgotinib Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Filgotinib Tablets Sales Mode & Process
  6. 9.2 Filgotinib Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Filgotinib Tablets Distributors
  9. 9.2.3 Filgotinib Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst